Related Experiment Video
Updated: May 30, 2026

Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
Published on: April 11, 2012
Plasminogen activator inhibitor type I contributes to protective immunity during experimental Gram-negative sepsis
L M Kager1, W J Wiersinga, J J T H Roelofs
1Center for Experimental and Molecular Medicine, Center for Infection and Immunity Amsterdam, Amsterdam, the Netherlands. l.m.kager@amc.uva.nl
Background:
Melioidosis is a frequent cause of sepsis in Southeast Asia caused by the Gram-negative bacterium Burkholderia pseudomallei. Patients with melioidosis have elevated circulating levels of plasminogen activator inhibitor type 1 (PAI-1), an important regulator of inflammation and fibrinolysis.
Objectives:
In this study, we aimed to investigate the role of PAI-1 during melioidosis.
Methods:
Wild-type (WT) and PAI-1-deficient (PAI-1-/1(-/-) ) mice were intranasally infected with B. pseudomallei. Mice were killed after 24, 48 or 72 h. Lungs, liver and blood were harvested for measurement of bacterial loads, cytokines, clinical chemistry, histopathology, and coagulation parameters. Additionally, survival studies were performed.
Results:
PAI-1(-/-) mice demonstrated enhanced susceptibility to B. pseudomallei infection, as shown by a strongly increased mortality rate (100% vs. 58% among WT mice, P < 0.001), associated with enhanced bacterial loads in lungs, liver, and blood. Additionally, PAI-1(-/-) mice showed elevated levels of proinflammatory cytokines in lungs and plasma, accompanied by enhanced local and systemic coagulation activation (thrombin-antithrombin complexes and D-dimer), increased hepatocellular injury (plasma aspartate aminotransferase and alanine aminotransferase), and renal failure (plasma creatinine and urea).
Conclusions:
PAI-1 has a protective role during severe Gram-negative sepsis caused by B. pseudomallei by limiting bacterial growth, inflammation, and coagulation, and probably, as a consequence thereof, distant organ injury.
Insights
Plasminogen activator inhibitor type 1 (PAI-1) protects against severe Burkholderia pseudomallei sepsis. PAI-1 deficiency increases mortality, bacterial load, inflammation, and organ injury in melioidosis models.
Area of Science:
- Infectious Diseases
- Immunology
- Microbiology
Background:
- Melioidosis, caused by Burkholderia pseudomallei, is a significant cause of sepsis in Southeast Asia.
- Elevated levels of plasminogen activator inhibitor type 1 (PAI-1) are observed in melioidosis patients.
Purpose of the Study:
- To investigate the protective role of PAI-1 in experimental melioidosis.
- To understand PAI-1's influence on bacterial growth, inflammation, and coagulation during B. pseudomallei infection.
Main Methods:
- Intranasal infection of wild-type and PAI-1-deficient mice with B. pseudomallei.
- Assessment of bacterial loads, cytokine levels, coagulation parameters, organ injury markers, and survival rates.
- Histopathological analysis of lung, liver, and kidney tissues.
Main Results:
- PAI-1-deficient mice exhibited a 100% mortality rate compared to 58% in wild-type mice.
- Increased bacterial loads, heightened proinflammatory cytokine levels, and enhanced coagulation activation were observed in PAI-1-deficient mice.
- Significant hepatocellular injury and renal failure were noted in PAI-1-deficient animals.
Conclusions:
- PAI-1 plays a crucial protective role in severe Gram-negative sepsis caused by B. pseudomallei.
- PAI-1 limits bacterial proliferation, dampens inflammation, and mitigates coagulation abnormalities, thereby reducing distant organ damage.
Related Concept Videos
Determinants of Bacterial Pathogenicity and Virulence
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Acute Inflammation III: Local and Systemic Effects
Inhibitors of Gram-positive Cell Wall Synthesis
Regulation of Bacterial Virulence
Gene Regulation in Microbial Communities: Quorum Sensing
